custom image

Innate Immunity: Mechanisms and Modulation

April 12-15, 2021 | 8:00AM EDT | 12:00PM UTC | 2:00PM CEST*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

The innate immune system is the first line of response to pathogens and tissue injury. Specialized cells have evolved mechanisms to detect microbial and distress signals and translate these into effector mechanisms that fight infections, amplify inflammation, initiate acquired immunity and eventually resolve. Although the innate immune response is usually associated with infectious disease, it has been implicated in a broad range of diseases, including cancer, autoimmunity, degenerative and vascular diseases. This conference provides multidisciplinary perspectives on innate immunity, from fundamental science to clinical aspects of disease, as well as therapeutic approaches to immune modulation. The conference program will focus on recent advances in this rapidly developing field. Presentations will provide new insights into mechanisms of microbial and distress sensing and the effector mechanisms of innate immune cells including macrophages, neutrophils, dendritic cells and innate lymphoid cells. The program will also highlight new approaches to understanding protective and pathogenic innate immune function, and emerging therapeutic opportunities for targeting these mechanisms in disease.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk


Program Details

Keynote Speaker

custom image

Hao Wu, PhD
Harvard Medical School, Boston Children's Hospital

Speaking at this eSymposia

Andrea Ablasser

Ecole Polytechnique Fédérale de Lausanne, Switzerland

Clare E. Bryant

University of Cambridge, UK

Xuetao Cao

Nankai University and Chinese Academy of Medical Sciences, China

Susan B. Carpenter

University of California, Santa Cruz, USA

Vishva M. Dixit

Genentech, Inc., USA

Kate A. Fitzgerald

University of Massachusetts Medical School, USA

Raphaela Theresia Goldbach-Mansky

NIAID, National Institutes of Health, USA

Stacy M. Horner

Duke University Medical Center, USA

Tiffany Horng

ShanghaiTech University, China

Veit Hornung

Ludwig-Maximilians-University Munich, Germany

Kate L. Jeffrey

Harvard Medical School, USA

Thirumala-Devi Kanneganti

St. Jude Children's Research Hospital, USA

Mariana J. Kaplan

NIAMS, National Institutes of Health, USA

Kathryn J. Moore,

New York University Medical Center, USA

Gioacchino Natoli

Humanitas University, Italy

Luke A. J. O'Neill

Trinity Biomedical Sciences Institute, Ireland

Megan H. Orzalli

University of Massachusetts Medical School, USA

Venizelos Papayannopoulos

Francis Crick Institute, UK

Scott Pesiridis

GlaxoSmithKline, USA

Barbara Rehermann

NIDDK, National Institutes of Health, USA

Kate Schroder

University of Queensland, Australia

Gregory F. Sonnenberg

Weill Cornell Medicine, USA

Rotem Sorek

Weizmann Institute of Science, Israel

Hao Wu

Harvard Medical School, Boston Children's Hospital, USA

Arturo Zychlinsky

Max Planck Institute for Infection Biology, Germany


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Donate to Keystone Symposia

custom image